Latest News and Press Releases

Two additional published studies highlight WatchPAT’s accuracy and effectiveness in patients with Central Sleep Apnea (CSA) and Chronic Obstructive Pulmonary Disease (COPD) CAESAREA, Israel, Feb. ...

CAESAREA, Israel, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive...

CAESAREA, Israel, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive...

CAESAREA, Israel, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive...

- 2019 Fiscal Year Revenues Expected to Increase 29% to $31.1 Million to $31.3 Million - - Full Year 2020 Revenue Guidance of $39.5 Million to $42.0 Million - CAESAREA, Israel, Jan. 13,...

Selection of Itamar's WatchPAT home sleep apnea diagnostic system underscores the importance and significance of understanding sleep disorders to prevent and manage risk of heart disease and stroke ...

Collaboration Will Endeavor to Reach Millions Suffering from Undiagnosed and Untreated Sleep Apnea Sufferers CAESAREA, Israel and PETERBOROUGH, N.H., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Itamar...

- Third Quarter Revenues Increase 33% to $8.1 Million - - WatchPAT™ Revenues Increase 32% in the Third Quarter to $7.6 Million - - Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT - ...

CAESAREA, Israel, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for...